Delaware
|
11-2920559
|
|
(State of incorporation)
|
(I.R.S. Employer Identification No.)
|
8000 Regency Parkway, Suite 542, Cary, NC 27518
|
(Address of principal executive offices, including Zip Code)
|
(919) 380-5000
|
(
Registrant’s telephone number, including area code)
|
Securities registered pursuant to Section 12(b) of the Act:
|
NONE
|
Securities registered pursuant to Section 12(g) of the Act:
|
Common Stock, $.001 par value
|
Item
Number
|
Page
Number
|
|
PART I
|
||
1.
|
Business
|
1
|
1A.
|
Risk factors
|
7
|
1B
|
Unresolved Staff Comments
|
11
|
2.
|
Properties
|
11
|
3.
|
Legal Proceedings
|
11
|
4.
|
Mine Safety Disclosures
|
11
|
PART II
|
||
5.
|
Market For Registrant's Common Stock, Related Shareholder Matters and Issuer Purchases of Equity Securities.
|
12
|
6.
|
Selected Financial Data
|
12
|
7.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
13
|
7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
20
|
8.
|
Financial Statements and Supplementary Data
|
20
|
9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
20
|
9A.
|
Controls and Procedures
|
21
|
9B.
|
Other Information
|
21
|
PART III
|
||
10.
|
Directors, Executive Officers and Corporate Governance
|
22
|
11.
|
Executive Compensation
|
25
|
12.
|
Security Ownership of Certain Beneficial Owners and Management
|
30
|
13.
|
Certain Relationships and Related Transactions, and Director Independence
|
32
|
14.
|
Principal Accountant Fees and Services
|
32
|
PART IV
|
||
15.
|
Exhibits and Financial Statement Schedules
|
34
|
SIGNATURES
|
37
|
|
INDEX TO FINANCIAL STATEMENTS
|
F-1
|
●
|
Monitor for potential business rule, compliance, fraud, and company policy issues.
|
●
|
Identify inconsistent workflow or missing steps in given processes.
|
●
|
Publish configured events to stop and start call recording software (or any other purpose).
|
●
|
Identify the step(s) in any or all processes an object (an account, claim, product, etc.) has been through and also what the latest step was and the current step in process.
|
●
|
Define an “anticipated” sequence for a process and report the events as they happen regardless of order.
|
●
|
Distinguish the differences between top and bottom performers.
|
●
|
Pinpoint repetitive and manual tasks that could be automated.
|
●
|
Capture where and when data are cut or copied from applications.
|
●
|
Identify if employees are navigating several screens (clicking, alt + tab) to complete tasks.
|
●
|
Capture, analyze, and focus on key performance indicators and metrics.
|
●
|
Supply desktop activity data to third-party enterprise analysis and reporting applications (e.g., BI, BAM, BPM, WFM/WFO, Speech Analytics, Call Recording, etc.).
|
●
|
Improve application usage and better focus/leverage IT investments.
|
●
|
A Regional Bank -
A large U.S. regional bank selected Cicero XM software to provide intelligent unified desktop solutions for their customer service operations and throughout their enterprise. Leveraging existing applications, the new solution captures desktop activities, automates processes, provides user guidance, and displays composite views of information to improve user productivity and the customer experience.
|
●
|
Business Process Outsourcers
- use our software solution in contact centers to provide real time integration among existing back-office systems, eliminate redundant data entry, shorten call times, provide real-time data access and enhance customer service and service levels.
|
●
|
A financial institution
- uses our software solution to provide real-time integration among market data, customer account information, existing back-office systems and other legacy applications, eliminate redundant data entry, provide real-time data access and processing, and enhance customer service and service levels.
|
●
|
An insurance company
– Information technology and Cicero professionals created a Cicero desktop solution which integrated computer telephony integration, key business systems and numerous secondary applications in use in the contact centers and elsewhere within the organization. Using Cicero, the contact center agents now use a central, integrated dashboard to navigate between applications, with key information (like customer and policy numbers) passed automatically between applications.
|
●
|
Product functionality and features;
|
●
|
Availability and quality of support services;
|
●
|
Ease of product implementation;
|
●
|
Price;
|
●
|
Product reputation; and
|
●
|
Our financial stability.
|
●
|
Middleware software provides integration of applications through messages and data exchange implemented typically in the middle tier of the application architecture. This approach requires modification of the application source code and substantial infrastructure investments and operational expense. Reuters, TIBCO and IBM MQSeries are competitors in the middleware market.
|
●
|
CRM software offers application tools that allow developers to build product specific interfaces and custom applications. This approach is not designed to be product neutral and is often dependent on deep integration with our technology. Siebel and Salesforce.com are representative products in the CRM software category.
|
●
|
Recently, there have been several companies that offer capabilities similar to our software in that these companies advertise that they integrate applications without modifying the underlying code for those applications. OpenSpan is one company who advertises that they can non-invasively integrate at the point of contact or on the desktop.
|
●
|
make a special suitability determination for purchasers of our shares;
|
●
|
receive the purchaser's written consent to the transaction prior to the purchase; and
|
●
|
deliver to a prospective purchaser of our stock, prior to the first transaction, a risk disclosure document relating to the penny stock market.
|
2013
|
2012
|
|||||||||||||||
Quarter
|
High
|
Low
|
High
|
Low
|
||||||||||||
First
|
$ | 0.10 | $ | 0.05 | $ | 0.19 | $ | 0.05 | ||||||||
Second
|
$ | 0.06 | $ | 0.05 | $ | 0.19 | $ | 0.14 | ||||||||
Third
|
$ | 0.06 | $ | 0.03 | $ | 0.15 | $ | 0.08 | ||||||||
Fourth
|
$ | 0.04 | $ | 0.01 | $ | 0.09 | $ | 0.04 |
Plan Category
|
Number of Securities to
be issued upon exercise of
outstanding options
|
Weighted-average
exercise price of
outstanding options
|
Number of securities
remaining available under
equity compensation plans
(excluding securities reflected
in the first column)
|
|||||||||
Equity compensation plans approved by stockholders
|
3,396,210 | $ | 0.31 | 1,111,090 | ||||||||
Equity compensation plans not approved by stockholders
|
-0- | -- | -0- |
Years Ended December 31,
|
||||||||
2013
|
2012
|
|||||||
Revenue:
|
||||||||
Software
|
5.7 | % | 67.7 | % | ||||
Maintenance
|
65.7 | % | 22.2 | % | ||||
Services
|
28.6 | % | 10.1 | % | ||||
Total
|
100.0 | % | 100.0 | % | ||||
Cost of revenue:
|
||||||||
Software
|
1.3 | % | 11.7 | % | ||||
Maintenance
|
5.0 | % | 2.4 | % | ||||
Services
|
44.0 | % | 16.3 | % | ||||
Total
|
50.3 | % | 30.4 | % | ||||
Gross margin
|
49.7 | % | 69.6 | % | ||||
Operating expenses:
|
||||||||
Sales and marketing
|
64.9 | % | 31.6 | % | ||||
Research and product development
|
58.0 | % | 24.6 | % | ||||
General and administrative
|
48.1 | % | 15.8 | % | ||||
Total
|
171.1 | % | 72.1 | % | ||||
Loss from operations
|
(121.4 | )% | (2.5 | )% | ||||
Other income/(expense), net
|
(24.9 | )% | (0.6 | )% | ||||
Net loss
|
(146.3 | )% | (3.1 | )% |
2013
|
2012
|
|||||||
United States
|
100 | % | 100 | % |
Name
|
Age
|
Position(s)
|
||
John L Steffens
|
72
|
Director and Chairman
|
||
John Broderick
|
64
|
Director and Chief Executive Officer/Chief Financial Officer
|
||
Antony Castagno
|
46
|
Director and Chief Technology Officer
|
||
Mark Landis
|
72
|
Director
|
||
Bruce W. Hasenyager
|
72
|
Director
|
||
Jay R. Kingley
|
53
|
Director
|
||
Charles B. Porciello
|
78
|
Director
|
||
Bruce D. Miller
|
63
|
Director
|
||
John W. Atherton
|
71
|
Director
|
||
Don Peppers
|
63
|
Director
|
●
|
Setting the total compensation of our Chief Executive Officer and evaluating his performance based on corporate goals and objectives;
|
●
|
Reviewing and approving the Chief Executive Officer’s decisions relevant to the total compensation of the Company’s other executive officer;
|
●
|
Making recommendations to the Board of Directors with respect to equity-based plans in order to allow us to attract and retain qualified personnel; and
|
●
|
Reviewing director compensation levels and practices, and recommending, from time to time, changes in such compensation levels and practices of the Board of Directors.
|
●
|
Base salary;
|
●
|
Non-equity incentive plan compensation;
|
●
|
Long-term incentive compensation; and
|
●
|
Other benefits
|
Name and
Principal
Position
|
Fiscal
Year
|
Salary
|
Stock
Awards
(1)
|
Non- Equity
Incentive
Plan
Compensation
(2)
|
All Other
Compensation
(3)
|
Total
|
||||||||||||||||
John P. Broderick
|
2013
|
$ | 175,000 | -- | $ | 25,000 | $ | 5,627 | $ | 205,627 | ||||||||||||
Chief Executive Officer,
|
2012
|
$ | 175,000 | 75,000 | $ | 25,000 | $ | 6,462 | $ | 281,462 | ||||||||||||
Chief Financial Officer, | ||||||||||||||||||||||
Corporate Secretary | ||||||||||||||||||||||
Antony Castagno
|
2013
|
$ | 150,000 | -- | $ | 45,372 | $ | 6,289 | $ | 201,661 | ||||||||||||
Chief Technology Officer |
2012
|
$ | 150,000 | -- | -- | $ | 5,792 | $ | 155,792 | |||||||||||||
(1)
|
In November 2012, the Company issued Mr. Broderick a restricted stock award in the amount of 1,500,000 shares which will vest to him upon termination or a change of control. The Company valued the restricted stock award at the fair market value on the date of the award and is amortizing the total expense of $75,000 over the assumed life of two years.
|
|
(2)
|
Non-equity incentive plan compensation for Mr. Broderick includes a bonus for certain revenue transactions earned during fiscal year ended December 31, 2013 and 2012. The revenue transaction was the acceptance of the first contract greater than $300,000 for each fiscal year.
Non-equity incentive plan compensation for Mr. Castagno includes a bonus for any revenues in excess of his base salary when engaged in consulting services on behalf of the Company.
|
|
(3)
|
Other compensation includes the Company’s portion of major medical insurance premiums and long term disability premiums for named executives during fiscal year ended December 31, 2013 and 2012, respectively.
|
Option Awards
|
Stock Awards
|
||||||||||||||||||||
Name
|
Number of Securities Underlying Unexercised Options # Exercisable
(Vested)
|
Number of Securities Underlying Unexercised Unearned Options# Unexercisable
(Unvested)
|
Option Exercise price ($)
|
Option Expiration date
|
Number of Shares of Stock That Have Not Vested
|
Market Value of Shares of Stock That Have Not Vested
|
|||||||||||||||
John P. Broderick
|
5,000 | (1) | -- | $ | 31.00 |
02/18/2014
|
|||||||||||||||
549,360 | (2) | -- | $ | 0.51 |
08/17/2017
|
||||||||||||||||
75,000 | (3) | -- | $ | 0.09 |
08/20/2020
|
||||||||||||||||
549,630 | (4) | $ | 10,993 | ||||||||||||||||||
1,500,000 | (5) | $ | 30,000 | ||||||||||||||||||
Antony Castagno
|
75,000 | (3) | -- | $ | 0.09 |
08/20/2020
|
|||||||||||||||
(1)
|
These options were granted on February 18, 2004. This stock option vested and became exercisable in three equal annual installments with the first installment vesting on February 18, 2004.
|
(2)
|
These options were granted on August 17, 2007. This stock option vests in three equal installments with the first installment vesting on August 17, 2007.
|
(3)
|
These options were granted on August 20, 2010. This stock option vests in three equal installments with the first installment vesting on August 20, 2010.
|
(4)
|
These are restricted stock granted on August 17, 2007. The shares will vest to him upon his resignation or termination or a change of control.
|
(5)
|
These are restricted stock granted on November 9, 2012. The shares will vest to him in the event of the termination, with or without cause, of his employment by the Company or his resignation from the Company with or without cause or in the event of a change of control.
|
Base Salary
|
Restricted Shares Award
|
Deferred Compensation
|
Total Compensation and Benefits
|
|||||||||||||
John P. Broderick
|
||||||||||||||||
Death
|
$ | -- | $ | 40,993 | $ | 44,792 | $ | 85,785 | ||||||||
Disability
|
-- | 40,993 | 44,792 | 85,785 | ||||||||||||
Involuntary termination without cause
|
175,000 | 40,993 | 44,792 | 260,785 | ||||||||||||
Change in Control
|
175,000 | 40,993 | 44,792 | 260,785 | ||||||||||||
Antony Castagno
|
||||||||||||||||
Death
|
$ | -- | $ | -- | $ | 36,987 | $ | 36,987 | ||||||||
Disability
|
-- | -- | 36,987 | 36,987 | ||||||||||||
Involuntary termination without cause
|
75,000 | -- | 36,987 | 111,987 | ||||||||||||
Change in Control
|
-- | -- | 36,987 | 111,987 |
*
|
Represents less than one percent of the outstanding shares.
|
1.
|
The address of John L. Steffens is 65 East 55
th
Street, New York, N.Y. 10022.
|
2.
|
Includes 32,262,529 shares of common stock, 14,832 common shares issuable upon conversion of the Series A-1 Convertible Preferred Stock, 6,400,000 common shares issuable upon conversion of the Series B Convertible Preferred Stock, and 3,238,285 shares issuable upon the exercise of warrants and 18,000 shares subject to stock options.
|
3.
|
The address of Mr. Gallen is 299 Park Avenue New York, New York 10171.
|
4.
|
Ahab Partner, L.P. (“Partners”), Ahab International, Ltd. (“International”), Queequeg Partners, L.P. (“Queequeg”) and Queequeg, Ltd. (“Limited,” and collectively with Partners, International and Queequeg, the “Funds”) held in aggregate 9,283,173 shares of common stock, 1,667,000 common shares issuable upon conversion of the Series B Convertible Preferred Stock and warrants to acquire 416,667 shares of common stock. Jonathan Gallen possesses the sole power to vote and the sole power to direct the disposition of all securities of the Company held by the Funds. In addition, Jonathan Gallen held the power to direct the disposition of 100,000 shares of common stock held in private investment account. Accordingly, for the purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Mr. Gallen may be deemed to beneficially own 11,366,840 shares of common stock of the Company.
|
5.
|
The address of Mark and Carolyn P. Landis is 503 Lake Drive, Princeton, New Jersey 08540.
|
6.
|
Includes 3,771,717 shares of common stock, 1,326,136 common shares issuable upon conversion of the Series A-1 Convertible Preferred Stock and 12,000 shares subject to stock options.
|
7.
|
Includes 2,000,000 shares of common stock, 3,257,713 shares of common stock issuable upon conversion of one-half of the principal and accumulated interest of a $700,000 convertible promissory note and 5,811,320 common shares issuable upon the conversion of the Series B Convertible Preferred Stock issuable upon conversion of a convertible promissory note in the principal amount of $700,000 and accumulated interest of $172,000.
|
8.
|
Consists of 2,774,655 shares of common stock, 18,000 shares subject to stock options and warrants to acquire 100,000 shares of common stock. Mr. Miller has sole or shared voting or dispositive power with respect to the securities held by Delphi Partners, Ltd., which holds 509,267 shares of common.
|
9.
|
Includes 1,582,179 shares of common stock and 1,333,333 common shares issuable upon conversion of the Series B Convertible Preferred Stock, warrants to acquire 533,333 shares of common stock and 12,000 shares subject to stock options.
|
10.
|
Includes 3,248 shares of common stock. 629,360 shares subject to stock options exercisable within sixty (60) days and 2,049,360 shares of restricted stock that is awarded upon termination or change of control.
|
11.
|
Includes 148,784 shares of common stock, and 100 shares of common stock held in a self-directed IRA and 18,000 shares subject to stock options.
|
12.
|
Consists of 32,652 shares of common stock and 18,000 shares subject to stock options.
|
13.
|
Consists of 80,286 shares of common stock and 18,000 shares subject to stock options.
|
14.
|
Consists of 75,000 shares subject to stock options.
|
15.
|
Consists of 1,000 shares of common stock and 18,000 shares subject to stock options.
|
16.
|
Includes 1,634,934 shares of common stock and 1,000,000 common shares issuable upon conversion of the Series B Convertible Preferred Stock, warrants to acquire 450,000 shares of common stock.
|
17.
|
Includes shares issuable upon conversion of shares of preferred stock and exercise of options and warrants as described in above Notes for each director and officer.
|
Exhibit Number | Description | |
3.1
|
Certificate of Incorporation of Level 8 Systems, Inc., a Delaware corporation, as amended and restated December 29, 2006 (incorporated by reference to exhibit 3.1 to Level 8’s Form 8-K filed
January 17, 2007).
|
|
3.2
|
Certificate of Designation relating to Series A1 Convertible Redeemable Preferred Stock (incorporated by reference to exhibit 3.2 to Level 8’s Form 8-K filed January 17, 2007).
|
|
3.3
|
Certificate of Incorporation of Level 8 Systems, Inc., a Delaware corporation, as amended August 4, 2003 (incorporated by reference to exhibit 3.1 to Level 8’s Form 10-K filed March 31, 2004).
|
|
3.4
|
Bylaws of Level 8 Systems, Inc., a Delaware corporation (incorporated by reference to exhibit 3.2 to Level 8’s Form 10-K filed April 2, 2002).
|
|
3.5
|
Certificate of Designation relating to Series B Convertible Redeemable Preferred Stock (incorporated by reference to exhibit 3.1 to Level 8’s Form 8-K filed January 20, 2010).
|
|
4.1
|
Form of Long term Promissory Note Stock Purchase Warrant (incorporated by reference to exhibit 4.19 to Cicero Inc.’s Form 10-K filed March 31, 2008). | |
4.2
|
Form of Long term Promissory Note Stock Purchase Warrant (incorporated by reference to exhibit 4.17 to Cicero Inc.’s Form 10-K filed March 31, 2009).
|
|
4.3
|
Form of Amended Long term Promissory Note Stock Purchase Warrant (incorporated by reference to exhibit 4.3 to Cicero Inc.’s Form 10-K filed March 31, 2011).
|
|
Form of Investor Warrant Agreement (filed herewith)
|
||
10.2
|
Amended PCA Shell License Agreement, dated as of January 3, 2002, between Level 8 Systems, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to exhibit 10.2 to Level 8's Form 8-K, filed January 11, 2002).
|
|
10.3A
|
PCA Shell License Agreement between Level 8 Systems, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to exhibit 10.2 to Level 8’s Report on Form 8-K, filed September 11, 2000).
|
|
10.3B
|
OEM License Agreement between Cicero Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to exhibit 10.12A to Cicero Inc.’s Form 10-K filed March 31, 2008).
|
|
10.3C
|
Software Support and Maintenance Schedule between Cicero Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to exhibit 10.12A to Cicero Inc.’s Form 10-K filed March 31, 2008).
|
|
10.6
|
Level 8 Systems Inc. 1997 Stock Option Plan, as Amended and Restated (incorporated by reference to exhibit 10.2 to Level 8’s Registration Statement on Form S-1/A, filed September 22, 2000, File No. 333-44588).*
|
|
10.7A
|
Fifth Amendment to Level 8 Systems Inc. 1997 Stock Option Plan (incorporated by reference to exhibit 10.9A to Level 8’s Form 10-K filed April 2, 2002).*
|
|
10.8B
|
Seventh Amendment to Level 8 Systems Inc. 1997 Stock Option Plan (incorporated by reference to exhibit 10.14 B to Level 8’s Form 10-K, filed March 31, 2004).*
|
|
10.1
|
Cicero Inc. 2007 Employee Stock Option Plan (incorporated by reference to exhibit 10.22 to Cicero Inc.’s Form 10-K filed March 31, 2008).
|
|
10.11
|
Agreement and Promissory Note of Cicero Inc., dated October 30, 2007 among Cicero Inc. and BluePhoenix Solutions Ltd. (incorporated by reference to exhibit 10.23 to Cicero Inc.’s Form 10-K filed March 31, 2008).
|
|
10.12
|
Promissory Note of Cicero Inc., dated October 29, 2007 among Cicero Inc. and John L. Steffens (incorporated by reference to exhibit 10.24 to Cicero Inc.’s Form 10-K filed March 31, 2008).
|
|
10.15
|
Revolving Loan Agreement dated November 3, 2008 among Cicero Inc. and Barbara Sivan (incorporated by reference to exhibit 10.15 to Cicero Inc., Form 10-K filed March 31, 2009).
|
|
10.16
|
Employment Agreement between John P. Broderick and the Company effective January 1, 2012 (incorporated by reference to exhibit 10.16 to Cicero Inc., Form 10-K filed April 16, 2012).
|
10.17
|
Form of Long Term Promissory Note dated March 31, 2009 (incorporated by reference to exhibit 10.17 to Cicero Inc., Form 10-K filed March 31, 2009).
|
|
10.18
|
Employment Agreement between Antony Castagno and the Company effective January 1, 2012 (incorporated by reference to exhibit 10.16 to Cicero Inc., Form 10-K filed April 16, 2012).*
|
|
10.19
|
Asset Purchase Agreement dated January 15, 2010 between Cicero Inc., Vertical Thought Inc., and SOAdesk LLC (incorporated by reference to exhibit 2.1 to Cicero’s Form 8-K filed January 20, 2010).
|
|
10.2
|
Amendment No. 1 to the Purchase Agreement dated January 15, 2010 between Cicero Inc., Vertical Thought Inc., and SOADesk LLC (incorporated by reference to exhibit 2.1 to Cicero’s Form 8-K/A filed April 2, 2010).
|
|
10.21
|
Registration Rights Agreement, dated as of January 15, 2010, by and among Cicero Inc. and the Purchasers thereto (incorporated by reference to exhibit 4.4 to Cicero Inc.’s Form 8-K filed January 20, 2010)
|
|
Form of Short Term Secured Promissory Note of Cicero Inc. among Cicero Inc. and John Broderick (filed herewith).
|
||
10.23
|
Source Code License Agreement between Cicero Inc. and Convergys Customer Management Group Inc. (incorporated by reference to exhibit 10.16 to Cicero Inc., Form 10-K filed April 16, 2012).
|
|
10.9
|
Lease Agreement for Cary, N.C. offices, dated July 21,
2010, between Cicero Inc. and Regency Park Corporation (incorporated by reference to exhibit 10.9 to Cicero Inc.’s Form 10-K filed March 31, 2011).
|
|
10.24
|
Form of Short Term Promissory Note of Cicero Inc. among Cicero Inc. and John L. Steffens (incorporated by reference to exhibit 10.16 to Cicero Inc., Form 10-K filed April 16, 2012).
|
|
Form of Short Term Promissory Note of Cicero Inc. among Cicero Inc. and Antony Castagno (filed herewith).
|
||
10.26
|
Amended Employment Agreement between John P. Broderick and the Company effective January 1, 2012 (incorporated by reference to exhibit 10.26 to Cicero Inc., Form 10-K filed April 15, 2013)
|
|
Registration Rights Agreement, dated as of March 20, 2013, by and among Cicero Inc. and the Purchasers thereto (filed herewith)
|
||
Form of Securities Purchase Agreement by and among Cicero, Inc. and the Purchasers thereto (filed herewith)
|
||
Amended Employment Agreement between Antony Castagno and the Company effective July 3, 2013 (filed herewith)
|
||
14.1
|
Code of Ethics (incorporated by reference to exhibit 14.1 to Level 8’s Form 10-K/A, filed
March 31, 2004).
|
|
21.1
|
List of subsidiaries of the Company (filed herewith).
|
|
Consent of Cherry Bekaert LLP (filed herewith).
|
||
Certification of Chief Executive pursuant to Rule 13a-14(a) (filed herewith).
|
||
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) (filed herewith).
|
||
Certification of John P. Broderick pursuant to 18 USC § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
CICERO INC.
|
|||
|
By:
|
/s/ John P. Broderick | |
John P. Broderick
|
|||
Chief Executive Officer and Chief Financial Officer
|
|||
Date: March 31, 2014
|
Signature
|
Title
|
Date
|
||
/
s/John L. Steffens
|
Chairman of the Board
|
March 31, 2014
|
||
John L. Steffens | ||||
/s/ John P. Broderick
|
Chief Executive Officer/Chief Financial Officer
|
March 31, 2014
|
||
John P. Broderick | (Principal Executive and Financial and Accounting Officer) | |||
/s/ Antony Castagno
|
Chief Technology Officer
|
March 31, 2014
|
||
Antony Castagno | ||||
/s/ Mark Landis
|
Director
|
March 31, 2014
|
||
Mark Landis | ||||
/s/ Bruce Hasenyager
|
Director
|
March 31, 2014
|
||
Bruce Hasenyager | ||||
/s/ Jay Kingley
|
Director
|
March 31, 2014
|
||
Jay Kingley | ||||
/s/ Bruce D. Miller
|
Director
|
March 31, 2014
|
||
Bruce D. Miller | ||||
/s/ Charles Porciello
|
Director
|
March 31, 2014
|
||
Charles Porciello | ||||
/s/ John W. Atherton
|
Director
|
March 31, 2014
|
||
John W. Atherton | ||||
/s/ Don Peppers
|
Director
|
March 31, 2014
|
||
Don Peppers |
December 31,
2013
|
December 31,
2012
|
|||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash
|
$ | 5 | $ | 69 | ||||
Trade accounts receivable, net
|
1,125 | 1,247 | ||||||
Prepaid expenses and other current assets
|
208 | 289 | ||||||
Total current assets
|
1,338 | 1,605 | ||||||
Property and equipment, net
|
29 | 47 | ||||||
Intangible asset, net (Note 4)
|
-- | 28 | ||||||
Goodwill (Note 4)
|
2,832 | 2,832 | ||||||
Total assets
|
$ | 4,199 | $ | 4,512 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
Current liabilities:
|
||||||||
Short-term debt (Note 5)
|
$ | 456 | $ | 826 | ||||
Accounts payable
|
3,178 | 2,887 | ||||||
Accrued expenses:
|
||||||||
Salaries, wages, and related items
|
1,235 | 1,119 | ||||||
Other
|
417 | 271 | ||||||
Deferred revenue
|
1,382 | 1,389 | ||||||
Total current liabilities
|
6,668 | 6,492 | ||||||
Long-term debt (Note 6)
|
6,134 | 3,509 | ||||||
Total liabilities
|
12,802 | 10,001 | ||||||
Commitments and contingencies (Notes 13 and 14)
|
||||||||
Stockholders' deficit:
|
||||||||
Convertible preferred stock, $0.001 par value, 10,000,000 shares authorized
Series A-1 – 1,541.6 shares issued and outstanding at December 31, 2013 and 2012, $500 per share liquidation preference (aggregate liquidation value of $771)
|
-- | -- | ||||||
Series B – 10,400 shares issued and outstanding at December 31, 2013 and 2012, $500 per share liquidation preference (aggregate liquidation value of $5,200)
|
-- | -- | ||||||
Common stock, $0.001 par value, 215,000,000 shares authorized at December 31, 2013 and 2012; 85,806,247 issued and outstanding at December 31, 2013 and 73,094,286 issued and outstanding at December 31, 2012 (Note 9)
|
86 | 73 | ||||||
Common stock - subscribed
|
-- | 10 | ||||||
Additional paid-in-capital
|
237,135 | 236,919 | ||||||
Accumulated deficit
|
(245,824 | ) | (242,491 | ) | ||||
Total stockholders' deficit
|
(8,603 | ) | (5,489 | ) | ||||
Total liabilities and stockholders' deficit
|
$ | 4,199 | $ | 4,512 |
Years Ended December 31,
|
||||||||
2013
|
2012
|
|||||||
Revenue:
|
||||||||
Software
|
$ | 124 | $ | 4,061 | ||||
Maintenance
|
1,440 | 1,333 | ||||||
Services
|
628 | 603 | ||||||
Total operating revenue
|
2,192 | 5,997 | ||||||
Cost of revenue:
|
||||||||
Software
|
28 | 701 | ||||||
Maintenance
|
110 | 145 | ||||||
Services
|
964 | 979 | ||||||
Total cost of revenue
|
1,102 | 1,825 | ||||||
Gross margin
|
1,090 | 4,172 | ||||||
Operating expenses:
|
||||||||
Sales and marketing
|
1,423 | 1,897 | ||||||
Research and product development
|
1,272 | 1,476 | ||||||
General and administrative
|
1,055 | 949 | ||||||
Total operating expenses
|
3,750 | 4,322 | ||||||
Loss from operations before other income (charges)
|
(2,660 | ) | (150 | ) | ||||
Other income (charges):
|
||||||||
Interest expense
|
(545 | ) | (547 | ) | ||||
Other (Note 1)
|
(1 | ) | 509 | |||||
(546 | ) | (38 | ) | |||||
Net loss
|
(3,206 | ) | (188 | ) | ||||
8% preferred stock Series B dividend
|
127 | 127 | ||||||
Net loss applicable to common stockholders
|
$ | (3,333 | ) | $ | (315 | ) | ||
Loss per share – basic and diluted
|
$ | (0.04 | ) | $ | (0.00 | ) | ||
Average shares outstanding – basic and diluted
|
85,198 | 67,038 |
Common Stock | Preferred Stock |
Additional
Paid-in
|
Accumulated | |||||||||||||||||||||||||
|
Shares |
Amount
|
Shares |
Amount
|
Capital
|
(Deficit)
|
Total
|
|||||||||||||||||||||
Balance at December 31, 2011
|
47,444,524 | $ | 47 | 11,941 | -- | $ | 232,506 | $ | (242,176 | ) | $ | (9,623 | ) | |||||||||||||||
Dividend for preferred B stock
|
(127 | ) | (127 | ) | ||||||||||||||||||||||||
Beneficial conversion of preferred A stock
|
1,000 | -- | ||||||||||||||||||||||||||
Issuance of stock for payment of debt/interest
|
23,884,429 | 24 | 3,560 | 3,584 | ||||||||||||||||||||||||
Issuance of stock for payment of accrued dividends
|
1,765,333 | 2 | 263 | 265 | ||||||||||||||||||||||||
Common Stock – Subscription
|
10,200,000 | 10 | 500 | 510 | ||||||||||||||||||||||||
Options issued as compensation
|
48 | 48 | ||||||||||||||||||||||||||
Restricted shares issued as compensation
|
42 | 42 | ||||||||||||||||||||||||||
Net loss
|
(188 | ) | (188 | ) | ||||||||||||||||||||||||
Balance at December 31, 2012
|
83,294,286 | $ | 83 | 11,941 | -- | $ | 236,919 | $ | (242,491 | ) | $ | (5,489 | ) | |||||||||||||||
Dividend for preferred B stock
|
(127 | ) | (127 | ) | ||||||||||||||||||||||||
Issuance of stock for payment of debt/interest
|
198,000 | 10 | 10 | |||||||||||||||||||||||||
Issuance of stock for external consulting fees
|
673,720 | 1 | 34 | 35 | ||||||||||||||||||||||||
Issuance of common stock
|
1,640,241 | 2 | 80 | 82 | ||||||||||||||||||||||||
Options issued as compensation
|
8 | 8 | ||||||||||||||||||||||||||
Restricted shares issued as compensation
|
84 | 84 | ||||||||||||||||||||||||||
Net loss
|
(3,206 | ) | (3,206 | ) | ||||||||||||||||||||||||
Balance at December 31, 2013
|
85,806,247 | $ | 86 | 11,941 | -- | $ | 237,135 | $ | (245,824 | ) | $ | (8,603 | ) |
Years Ended December 31,
|
||||||||
2013
|
2012
|
|||||||
Cash flows from operating activities:
|
||||||||
Net loss
|
$ | (3,206 | ) | $ | (188 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
Depreciation and amortization
|
55 | 725 | ||||||
Stock compensation expense
|
92 | 90 | ||||||
Stock issuance for external consulting fees
|
35 | -- | ||||||
Bad debt expense
|
-- | 18 | ||||||
Gain on forgiveness of debt
|
-- | (598 | ) | |||||
Gain on write down of accrued liability
|
-- | (390 | ) | |||||
Changes in assets and liabilities:
|
||||||||
Trade accounts receivable
|
122 | (404 | ) | |||||
Prepaid expenses and other assets
|
81 | 123 | ||||||
Accounts payable and accrued expenses
|
453 | 354 | ||||||
Deferred revenue
|
(7 | ) | (222 | ) | ||||
Net cash used in operating activities
|
(2,375 | ) | (492 | ) | ||||
Cash flows from investing activities:
|
||||||||
Purchases of property and equipment
|
(9 | ) | (39 | ) | ||||
Net cash used in investing activities
|
(9 | ) | (39 | ) | ||||
Cash flows from financing activities:
|
||||||||
Issuance of common stock
|
65 | -- | ||||||
Common stock subscription
|
-- | 187 | ||||||
Borrowings under short and long-term debt
|
2,671 | 1,998 | ||||||
Repayments of short and long-term debt
|
(416 | ) | (1,769 | ) | ||||
Net cash provided by financing activities
|
2,320 | 416 | ||||||
Net decrease in cash
|
(64 | ) | (115 | ) | ||||
Cash at beginning of year
|
69 | 184 | ||||||
Cash at end of year
|
$ | 5 | $ | 69 | ||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
|
||||||||
Cash paid during the year for:
|
||||||||
Income taxes
|
$ | 12 | $ | 15 | ||||
Interest
|
$ | 19 | $ | 263 |
NOTE 1.
|
SUMMARY OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS
|
2013
|
2012
|
|||||||
Stock options
|
3,396,210 | 3,921,493 | ||||||
Warrants
|
6,281,333 | 5,928,285 | ||||||
Preferred stock
|
11,941,618 | 11,941,618 | ||||||
21,619,161 | 21,791,396 |
2013
|
2012
|
|||||||
Fair value of common stock
|
$ | 0.05 | $ | 0.14 | ||||
Expected life (in years)
|
9.99 years
|
9.85 years
|
||||||
Expected volatility
|
169 | % | 186 | % | ||||
Risk free interest rate
|
0.40 | % | 0.19 | % | ||||
Expected dividend yield
|
0 | % | 0 | % |
2013
|
2012
|
|||||||
Current trade accounts receivable
|
$ | 1,125 | $ | 1,247 |
2013
|
2012
|
|||||||
Computer equipment
|
$ | 143 | $ | 134 | ||||
Furniture and fixtures
|
24 | 24 | ||||||
Office equipment
|
35 | 35 | ||||||
202 | 193 | |||||||
Less: accumulated depreciation and amortization
|
(173 | ) | (146 | ) | ||||
$ | 29 | $ | 47 |
2013
|
2012
|
|||||||
Note payable related parties (a)
|
$ | 21 | $ | 3 | ||||
Notes payable (b)
|
435 | 823 | ||||||
$ | 456 | $ | 826 |
(a)
|
During 2012 and 2013, the Company entered into various short term notes
payable with John Broderick, the Chief Executive Officer and Chief Financial Officer, for various working capital needs. The notes bear interest at 12% and were unsecured. At December 31, 2012, the Company was indebted to Mr. Broderick in the approximate amount of $3,000. No interest was paid in fiscal 2012. At December 31, 2013, the Company was indebted to Mr. Broderick in the approximate amount of $6,000. No interest was paid in fiscal 2013.
|
(b)
|
The Company has issued a series of short term promissory notes with private lenders, which provide for short term borrowings, both secured by accounts receivable and unsecured. The notes in the aggregate amount of $435,000 and $407,000, respectively, as of December 31, 2013, and 2012 bear interest between 10% and 36% per annum. In March 2012, the Company converted $235,000 of these previously held notes into 1,566,667 shares of Company’s common stock.
|
2013
|
2012
|
|||||||
Note payable asset purchase agreement (a)
|
$ | 700 | $ | 700 | ||||
Note payable – related party (b)
|
4,398 | 1,773 | ||||||
Other long-term debt (c)
|
1,036 | 1,036 | ||||||
$ | 6,134 | $ | 3,509 |
(a)
|
In January 2010, per the Asset Purchase Agreement, the Company entered into an unsecured convertible promissory note with SOAdesk for $700,000 with an annual interest rate of 5%. The note was originally scheduled to mature on March 31, 2010 but was subsequently amended through a series of amendments, the maturity date was extended to June 30, 2015. At December 31, 2013, the Company was indebted to SOAdesk in the amount of $700,000 in principal and $139,000 in interest.
|
(b)
|
From time to time during 2012 through 2013, the Company entered into several short term notes payable with John L. (Launny) Steffens, the Chairman of the Board of Directors, for various working capital needs. The notes bear interest at 12% per year and are unsecured. In December 2012, Mr. Steffens converted $300,000 of his debt into a subscription of 6,000,000 shares of the Company’s common stock at a price of $0.05 per share as part of a private investment in the Company’s stock. At December 31, 2012, the Company was indebted to Mr. Steffens in the approximate amount of $1,773,000 of principal and $148,000 in interest. In March 2013, Mr. Steffens agreed to extend the maturity date of all outstanding short term notes until April 1, 2014. As such this amount has been classified as long term debt as of December 31, 2012. At December 31, 2013, the Company was indebted to Mr. Steffens in the approximate amount of $4,398,000 of principal and $505,000 in interest. In March 2014, Mr. Steffens agreed to extend the maturity date of all outstanding short term notes until June 30, 2015. As such this amount has been classified as long term debt.
|
(c)
|
In January 2010, as part of the Asset Purchase Agreement, the Company entered into an unsecured Convertible Promissory Note with SOAdesk in the amount of $1,000,000. The note bears interest at 5% and is due January 14, 2015. The note is only convertible into shares of the Company’s common stock at the rate of one share for every $0.15 of principal and interest due under the note. The note is convertible at the option of the holder with one-third convertible in January 2011, two-thirds convertible in January 2012, and the entire note convertible in January 2013 or at maturity. In March 2012, SOAdesk elected to convert $300,000 of the outstanding note balance into 2,000,000 shares of Company’s Common Stock. At December 31, 2012 the Company was indebted to SOAdesk in the amount of $700,000 of principal and $137,000 in interest. At December 31, 2013, the Company was indebted to SOAdesk in the amount of $700,000 of principal and $172,000 in interest.
|
Year
|
||||
2015
|
$ | 6,134,000 | ||
$ | 6,134,000 |
2013
|
2012
|
|||||||
Expected income tax benefit at statutory rate (34%)
|
$ | (1,090 | ) | $ | (64 | ) | ||
State taxes, net of federal tax benefit
|
(192 | ) | (10 | ) | ||||
Effect of change in valuation allowance
|
(9,876 | ) | (9,848 | ) | ||||
Non-deductible expenses
|
4 | 6 | ||||||
Expiration of net operating loss deductions
|
11,154 | 9,916 | ||||||
Total
|
$ | -- | $ | -- |
2013
|
2012
|
|||||||
Current assets:
|
||||||||
Accrued expenses, non-tax deductible
|
$ | 99 | $ | 5 | ||||
Deferred revenue
|
553 | 556 | ||||||
Contingent payments
|
(831 | ) | (831 | ) | ||||
Noncurrent assets:
|
||||||||
Stock compensation expense
|
580 | 543 | ||||||
Loss carryforwards
|
61,942 | 71,122 | ||||||
Depreciation and amortization
|
1,105 | 1,929 | ||||||
63,448 | 73,324 | |||||||
Less: valuation allowance
|
(63,448 | ) | (73,324 | ) | ||||
$ | -- | $ | -- |
|
Number of Options
|
Option Price
Per Share
|
Weighted Average
Exercise Price
|
Aggregate Intrinsic Value
|
||||||||||||
Balance at December 31, 2011
|
4,296,193 | 0.06-39.00 | $ | 0.39 | ||||||||||||
Granted
|
70,000 | 0.05-0.19 | $ | 0.14 | ||||||||||||
Forfeited
|
(440,000 | ) | 0.06-31.00 | $ | 0.35 | |||||||||||
Expired
|
(4,700 | ) | 34.00-39.00 | $ | 36.39 | |||||||||||
Balance at December 31, 2012
|
3,921,493 | 0.06-46.00 | $ | 0.36 | ||||||||||||
Granted
|
25,000 | 0.05 | $ | 0.05 | ||||||||||||
Forfeited
|
(544,733 | ) | 0.06-46.00 | $ | 0.44 | |||||||||||
Expired
|
(5,550 | ) | 22.00-26.00 | $ | 25.57 | |||||||||||
Balance at December 31, 2013
|
3,396,210 | 0.05-46.00 | $ | 0.31 | $ | 0.00 |
|
Number of Options
|
Option Price
Per Share
|
Weighted Average
Exercise Price
|
|||||||||
Balance at December 31, 2011
|
952,414 | 0.06-0.10 | $ | 0.08 | ||||||||
Granted
|
70,000 | 0.05-0.19 | $ | 0.14 | ||||||||
Vested
|
(805,747 | ) | 0.05-0.09 | $ | 0.08 | |||||||
Forfeited
|
(75,000 | ) | 0.08-0.09 | $ | 0.08 | |||||||
Balance at December 31, 2012
|
141,667 | 0.05-0.19 | $ | 0.10 | ||||||||
Granted
|
25,000 | 0.05 | $ | 0.05 | ||||||||
Vested
|
(33,334 | ) | 0.05-0.19 | $ | 0.12 | |||||||
Forfeited
|
(8,333 | ) | 0.16 | $ | 0.16 | |||||||
Balance at December 31, 2013
|
125,000 | 0.05-0.19 | $ | 0.08 |
Exercise Price
|
Number
Outstanding
|
Remaining Contractual Life for Options Outstanding
|
Number
Exercisable
|
Weighted Average Exercise
Price
|
||||||||||||||
$ | 0.05-0.08 | 725,000 | 7.7 | 608,333 | $ | 0.07 | ||||||||||||
0.09 | 997,750 | 6.6 | 997,750 | 0.09 | ||||||||||||||
0.10-0.37 | 370,000 | 5.4 | 361,667 | 0.15 | ||||||||||||||
0.38-31.00 | 1,303,460 | 3.6 | 1,303,460 | 0.65 | ||||||||||||||
3,396,210 | 5.6 | 3,271,210 | $ | 0.32 |
Number of Warrants |
Warrant Price
Per Share
|
Weighted Average Exercise Price | ||||||||||
Balance at December 31, 2012
|
5,928,285 | $ | 0.08-$0.25 | $ | 0.22 | |||||||
Issued
|
353,048 | $ | 0.10-$0.20 | $ | 0.19 | |||||||
Exercised
|
-- | -- | -- | |||||||||
Forfeited
|
-- | -- | -- | |||||||||
Balance at December 31, 2013
|
6,281,333 | $ | 0.10-$0.25 | $ | 0.22 |
Lease
Commitments
|
||||
2014
|
$ | 59 | ||
$ | 59 |
X
|
=
|
Y x (A-B)/A
|
|
where
|
X
|
=
|
the number of Warrant Shares to be issued to the Holder;
|
Y
|
=
|
the number of Warrant Shares with respect to which this Warrant is being exercised;
|
|
A
|
=
|
the Market Price of a share of Common Stock as of the Date of Exercise; and
|
|
B
|
=
|
the Exercise Price.
|
|
Cicero Inc.
|
8000 Regency Parkway
|
Cary, NC 27511
|
Tel: (919) 380-5000
|
Fax: (919) 380-5121
|
Attn: John P. Broderick
|
Tel:
|
Fax:
|
With a copy to (which copy shall not constitute notice):
|
Tel:
|
Fax:
|
CICERO INC.
|
|||
|
By:
|
||
Name: | John Broderick | ||
Title: | CEO/CFO | ||
HOLDER
|
|||
By:
|
|||
Name: | |||
Title: |
TO:
|
Cicero Inc.
|
By:
|
||
Name: | ||
Social Security Number or Tax Identification Number:
|
||
Date:
|
||
TO:
|
Cicero Inc.
|
|
By:
|
||
Name: | ||
Social Security Number or Tax Identification Number:
|
||
Date:
|
||
Dated:
|
Signature:
|
(Signature must conform in all respects to name of Holder as specified on the face of the Warrant)
|
|
1.
|
the Maker failed to make payment on time or in the amount due, which failure continues uncured ten (10) days after Maker’s receipt of written notice from the Lender specifying such failure; or
|
2.
|
the Maker goes into bankruptcy, whether through the Maker’s own choice or not, or makes an assignment for the benefit of creditors, or admits his inability to pay his debts as they become due.
|
1.
|
the Lender may, without further notice, accelerate the due date on this Note and all unpaid principal, interest, and all other charges immediately shall be due and payable;
|
2.
|
the Lender may demand additional security or that new parties become obligated to pay this note;
|
3.
|
the Lender may make use of any remedy the Lender has under state or federal law; and
|
4.
|
the Lender may make use of any remedy given to the Lender in any agreement securing or entered into in connection with this Note.
|
(1)
|
except as expressly provided in this Note, demand payment of amounts due (presentation);
|
(2)
|
obtain official certification of nonpayment (protest); or
|
(3)
|
except as expressly provided in this Note, give notice to the amounts due have not been paid (notice of dishonor).
|
1.
|
the Maker failed to make payment on time or in the amount due, which failure continues uncured ten (10) days after Maker’s receipt of written notice from the Lender specifying such failure; or
|
2.
|
the Maker goes into bankruptcy, whether through the Maker’s own choice or not, or makes an assignment for the benefit of creditors, or admits his inability to pay his debts as they become due.
|
1.
|
the Lender may, without further notice, accelerate the due date on this Note and all other charges immediately shall be due and payable;
|
2.
|
the Lender may demand additional security or that new parties become obligated to pay this note; and
|
3.
|
the Lender may make use of any remedy the Lender has under state or federal law.
|
(1)
|
except as expressly provided in this Note, demand payment of amounts due (presentation);
|
(2)
|
obtain official certification of nonpayment (protest); or
|
(3)
|
except as expressly provided in this Note, give notice to the amounts due have not been paid (notice of dishonor).
|
If to the Company:
|
Cicero Inc.
8000 Regency Parkway
Cary, NC 27518
Attention: John Broderick
Tel. No.: (919) 380-5000
Fax No.: (919) 380-5121
|
If to any Purchaser:
|
To the address set forth on the signature page hereto
|
COMPANY:
|
|||
CICERO INC.
|
|||
|
By:
|
||
Name: | John Broderick | ||
Title: | CEO/CFO | ||
PURCHASER:
|
|||
[PURCHASER]
|
|||
|
By:
|
||
Name: | John Broderick | ||
Title: | CEO/CFO | ||
Address: | |||
Email:
|
|||
●
|
ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
|
●
|
block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;
|
●
|
purchases by a broker-dealer as principal and resales by the broker-dealer for its account;
|
●
|
an exchange distribution in accordance with the rules of the applicable exchange;
|
●
|
privately negotiated transactions;
|
●
|
broker-dealers may agree with the selling security holders to sell a specified number of such shares at a stipulated price per share;
|
●
|
a combination of any of these methods of sale; and
|
●
|
any other method permitted pursuant to applicable law.
|
A
|
Complete the following items relating to the Agreement
.
|
|
1.
|
Review the entire Agreement (including the exhibits thereto) and complete and execute the Investor Signature Page. The Agreement must be executed by an individual authorized to bind the Purchaser.
|
|
2.
|
Exhibit A-1 - Stock Certificate Questionnaire:
|
|
3.
|
Exhibit A-2 - Investor Certificate:
|
|
4.
|
Return, via facsimile, (i) the signed Agreement, including the properly completed Exhibits A-1 and A-2, (ii) the signed Warrant, and (iii) the signed Registration Rights Agreement to the Company: Cicero, Inc. at (919) 380-5121, Attn: John Broderick, CEO/CFO
|
|
5.
|
After completing instruction number four (4) above, deliver (i) the original signed Agreement, including the properly completed Exhibits A-1 and A-2, (ii) the original signed Warrant, and (iii) the original signed Registration Rights Agreement to the Company: Cicero, Inc., 8000 Regency Parkway, Suite 542, Cary, NC 27518 Attn: John Broderick, CEO/CFO
|
B.
|
Payment Instructions
. Forward payment for the total amount of your subscription (as indicated under “Aggregate Purchase Price” on the Investor Signature Page) in U.S. dollars by wire transfer to the Company as follows:
|
1.
|
The exact name that the Securities are to be registered in (this is the name that will appear on the stock certificate(s)). You may use a nominee name if appropriate:
|
2.
|
The relationship between the Purchaser of the Securities and the Registered Holder listed in response to item 1 above:
|
3.
|
The mailing address, telephone and telecopy number and email address of the Registered Holder listed in response to item 1 above:
|
4.
|
The Tax Identification Number of the Registered Holder listed in response to item 1 above:
|
|
____
|
Revocable Trust (identify each grantor and indicate under what circumstances the trust is revocable by the grantor):
|
|
____
|
Other type of Trust (indicate type of trust and, for trusts other than pension trusts, name the grantors and beneficiaries):
|
( |
) |
|
___
|
1.
|
A bank as defined in Section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;
|
|
___
|
2.
|
A broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934;
|
|
___
|
3.
|
An insurance company as defined in Section 2(13) of the Securities Act;
|
|
___
|
4.
|
An investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that Act;
|
|
___
|
5.
|
A Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958;
|
|
___
|
6.
|
A plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;
|
|
___
|
7.
|
An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment advisor, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors;
|
|
___
|
8.
|
A private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940;
|
|
___
|
9.
|
Any partnership or corporation or any organization described in Section 501(c)(3) of the Internal Revenue Code or similar business trust, not formed for the specific purpose of acquiring the Shares, with total assets in excess of $5,000,000;
|
|
___
|
10.
|
A trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Shares, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) of the Exchange Act;
|
|
___
|
11.
|
An entity in which all of the equity owners qualify under any of the above subparagraphs. If the undersigned belongs to this investor category only, list the equity owners of the undersigned, and the investor category which each such equity owner satisfies:
|
1.
|
Consulting Services
. The Company hereby agrees to allow Employee to perform consulting services on behalf of Cicero Inc.
|
2.
|
Duties of Employee
. Employee will provide consulting services to DTC Systems and be based in Georgia or North Carolina at the discretion of DTC. Employee will devote a minimum of 40 hours per week to consulting services during its term. Employee will use his best efforts to remain in contact with Cicero’s Development and Sales teams and assist whenever possible and otherwise carryout his duties as Chief Technology Officer.
|
3.
|
Term
. The term of this Addendum shall be no longer than six (6) months.
|
|
(a)
|
Annual Salary
. During the term of this Addendum, Cicero will continue to pay Employee’s semi-monthly salary payments for so long as invoice payments are received from DTC Systems and the Consulting Agreement terms and conditions between the Company and DTC Systems are met in a timely manner. It is agreed that the amount invoiced to DTC Systems shall be paid to Employee, first in the form of employee’s base salary; and second in the form of a bonus for any amount invoiced that exceeds Employee’s base salary. All applicable Employee/Employer taxes shall be withheld at the time such salary and/or bonus payments are made.
|
5.
|
Other Benefits
. Employee will be entitled to continue such fringe benefits as may be provided from time-to-time by the Company to its employees, including, but not limited to, group health insurance, life and disability insurance, and any other fringe benefits now or hereafter provided by the Company to its employees. , The Company reserves the right to change or discontinue any employee benefit plans or programs now being offered to its employees; provided, however, that all benefits provided for employees of the same position and status as Employee will be provided to Employee on an equal basis.
|
6.
|
Business Expenses
. Employee will be reimbursed for all reasonable expenses incurred in the discharge of Employee's duties under this Addendum pursuant to the Company's standard reimbursement policies.
|
7.
|
Withholding
. The Company will deduct and withhold from the payments made to Employee under this Addendum, state and federal income taxes, FICA and other amounts normally withheld from compensation due employees.
|
8.
|
Non-Disclosure of Proprietary Information
. Employee recognizes and acknowledges that the Trade Secrets (as defined below) and Confidential Information (as defined below) of the Company and its affiliates, and all physical embodiments thereof (as they may exist from time-to-time, collectively, the “Proprietary Information”) are valuable, special and unique assets of the Company's and its affiliates' businesses. Employee further acknowledges that access to such Proprietary Information is essential to the performance of Employee's duties under this Addendum. Therefore, in order to obtain access to such Proprietary Information, Employee agrees that, except with respect to those duties assigned to him by the Company, Employee will hold in confidence all Proprietary Information and will not reproduce, use, distribute, disclose, publish or otherwise disseminate any Proprietary Information, in whole or in part, and will take no action causing, or fail to take any action necessary to prevent causing, any Proprietary Information to lose its character as Proprietary Information, nor will Employee make use of any such information for Employee's own purposes or for the benefit of any person, firm, corporation, association or other entity (except the Company) under any circumstances.
|
|
9.
Non-Solicitation Covenants
. Employee agrees that during Employee's consulting engagement and for a period of two (2) years following the termination of Employee's employment for whatever reason, Employee will not, directly or indirectly, on Employee's own behalf or in the service of or on behalf of any other individual or entity, divert, solicit or attempt to divert or solicit any individual or entity (i) who is a client of the Company at any time during the six (6)-month period prior to Employee's termination of employment with the Company (“Client”), or was actively sought by the Company as a prospective client, and (ii) with whom Employee had material contact while employed by or providing services to or for the benefit of the Company, to provide similar services or products as such provided by Employee for the Company, to such Clients or prospects. Employee further agrees and represents that during Employee's employment by the Company and for a period of two (2) year following any termination of Employee's employment for whatever reason, Employee will not, directly or indirectly, on Employee's own behalf or in the service of, or on behalf of any other individual or entity, divert, solicit or hire away, or attempt to divert, solicit or hire away, to or for any individual or entity which is engaged in providing similar services or products to that provided by the Company, any person employed by the Company for whom Employee had supervisory responsibility or with whom Employee had material contact while employed by or providing services to or for the benefit of the Company, whether or not such employee is a full-time employee or temporary employee of the Company, whether or not such employee is employed pursuant to written agreement and whether or not such employee is employed for a determined period or at-will. For purposes of this Addendum, “material contact” exists between Employee and a Client or potential Client when (1) Employee established and/or nurtured the Client or potential Client; (2) the Client or potential Client and Employee interacted to further a business relationship or contract with the Company, ; (3) Employee had access to confidential information and/or marketing strategies or programs regarding the Client or potential Client; and/or (4) Employee learned of the Client or potential Client through the efforts of the Company, providing Employee with confidential Client information, including but not limited to the Client’s identify, for purposes of furthering a business relationship.
|
|
10.
Remedies
. Employee agrees and acknowledges that the violation of any of the covenants or agreements contained in Sections 8 and 9 of this Addendum would cause irreparable injury to the Company, that the remedy at law for any such violation or threatened violation thereof would be inadequate, and that the Company will be entitled, in addition to any other remedy, to temporary and permanent injunctive or other equitable relief without the necessity of proving actual damages or posting a bond.
|
|
11.
Severability
. In case one or more of the provisions contained in this Addendum is for any reason held to be invalid, illegal or unenforceable in any respect, the parties agree that it is their intent that the same will not affect any other provision in this Addendum, and this Addendum will be construed as if such invalid or illegal or unenforceable provision had never been contained herein. It is the intent of the parties that this Addendum be enforced to the maximum extent permitted by law.
|
|
12.
Entire Agreement
. This Addendum embodies the entire agreement of the parties relating to the subject matter of this Addendum and supersedes all prior agreements, oral or written, regarding the subject matter hereof. No amendment or modification of this Addendum will be valid or binding upon the parties unless made in writing and signed by the parties.
|
|
13.
Governing Law
. This Addendum is entered into and will be interpreted and enforced pursuant to the laws of the State of North Carolina. The parties hereto hereby agree that the appropriate forum and venue for any disputes between any of the parties hereto arising out of this Addendum shall be any federal court in the state where the Employee has his principal place of residence and each of the parties hereto hereby submits to the personal jurisdiction of any such court. The foregoing shall not limit the rights of any party to obtain execution of judgment in any other jurisdiction. The parties further agree, to the extent permitted by law, that a final and unappealable judgment against either of them in any action or proceeding contemplated above shall be conclusive and may be enforced in any other jurisdiction within or outside the United States by suit on the judgment, a certified exemplified copy of which shall be conclusive evidence of the fact and amount of such judgment.
|
By: | |||||
Name: | John Broderick | Name: | Antony Castagno | ||
Title: | CEO/CFO | Title: | CTO |
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;
|
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and
|
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: March 31, 2014
|
/s/ John P. Broderick | ||
John P. Broderick | |||
Chief Executive Officer
|
|||
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;
|
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and
|
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: March 31, 2014
|
/s/ John P. Broderick | ||
John P. Broderick | |||
Chief Financial Officer
|
|||
By: | /s/ John P. Broderick | ||
John P. Broderick | |||
Chief Executive and Financial Officer
|
|||
(Principal Financial and Accounting Officer)
|
|||
March 31, 2014
|
|||